Athanasios D. Anastasilakis, Dimitrios G. Goulis, Marina Kita, Avraam Avramidis
OBJECTIVE: Bisphosphonates are potent antiresorptive agents used for a spectrum of metabolic bone diseases. The aim of this study was to compare the adverse effects (AEs) of alendronate, etidronate and risedronate prescribed in a non-selected population, attending a single institution on an outpatient basis…